Navigation Links
Isis Initiates Phase 1 Study of ISIS-PTP1BRx to Treat Type 2 Diabetes
Date:7/21/2011

position in antisense technology to discover and develop novel drugs for its product pipeline and for its partners.  Isis' broad pipeline consists of 24 drugs to treat a wide variety of diseases with an emphasis on cardiovascular, metabolic and severe and rare/neurodegenerative diseases, and cancer.  Isis' partner, Genzyme, a sanofi company, plans to commercialize Isis' lead product, mipomersen, in 2012.  Isis' patents provide strong and extensive protection for its drugs and technology.  Additional information about Isis is available at www.isispharm.com.

ISIS PHARMACEUTICALS' FORWARD-LOOKING STATEMENT

This press release includes forward-looking statements regarding the development, activity, therapeutic potential and safety of Isis' antisense inhibitors of PTP-1B including ISIS-PTP1BRx and planned commercialization of mipomersen.  Any statement describing Isis' goals, expectations, financial or other projections, intentions or beliefs is a forward-looking statement and should be considered an at-risk statement.  Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of discovering, developing and commercializing drugs that are safe and effective for use as human therapeutics, and in the endeavor of building a business around such drugs.  Isis' forward-looking statements also involve assumptions that, if they never materialize or prove correct, could cause its results to differ materially from those expressed or implied by such forward-looking statements.  Although Isis' forward-looking statements reflect the good faith judgment of its management, these statements are based only on facts and factors currently known by Isis.  As a result, you are cautioned not to rely on these forward-looking statements.  These and other risks concerning Isis' programs are described in additional detail in Isis' annual rep
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine
2. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
3. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. MedImmune Initiates Phase 2a Multi-Dose Study in Patients with Asthma
6. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
7. Nuvelo Re-Initiates SONOMA-3 Trial of Alfimeprase in Patients With Catheter Occlusion
8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
9. Prolexys Pharmaceuticals Initiates Phase 1 Study
10. Isis Initiates Phase 1 Study of ISIS 325568 Targeting Glucagon Receptor to Treat Type 2 Diabetes
11. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... OAK, Mich. , March 26, 2015 ... have performed the Midwest,s first commercial implant of ... Administration for patients with non-valvular atrial fibrillation. The Watchman ... long-term use of blood-thinning warfarin medication to reduce the ... most common heart rhythm disorder affecting more than 5 ...
(Date:3/26/2015)... -- CCS Medical ("CCS"), one of the nation,s leading ... chronic conditions, has named Rodney Carson ... 23.  Mr. Carson joins CCS from MDLIVE, the ... of Operations. Prior to MDLIVE, ... of Operations at NationsHealth, (n/k/a Convey Health Solutions), ...
(Date:3/26/2015)... , March 26, 2015 ... announced the addition of the "Global Smart ... report to their offering.      (Logo: ... Wearable Healthcare Devices and Services market to grow ... 2015-2019 The report covers the present ...
Breaking Medicine Technology:Beaumont Hospital, Royal Oak among first to offer alternative to blood-thinning medications for atrial fibrillation 2Beaumont Hospital, Royal Oak among first to offer alternative to blood-thinning medications for atrial fibrillation 3CCS Medical Team Hires Industry Operator Rodney Carson as CEO 2Global Smart Wearable Healthcare Devices and Services Market 2015-2019 WITH Apple, At&T, Ee, Google, Samsung, Sprint, Telefonica & T-Mobile Dominating 2
... NEW YORK and HOBOKEN, N.J., Jan. 18, 2011 ... second grant recipient of the Octapharma 25th Anniversary ... at The Mount Sinai Medical Center . The ... on human protein therapies in hematology, immune therapy, intensive ...
... MINNEAPOLIS, Jan. 18, 2011 Zyga Technology, Inc. ... Administration (FDA) has granted the company 510(K) clearance ...  The SImmetry Sacroiliac Joint Fusion System is intended ... joint disruptions. The SImmetry Sacroiliac Joint Fusion System ...
Cached Medicine Technology:Octapharma Targets Primary Immune Deficiency Research With Grant for The Mount Sinai Medical Center 2Octapharma Targets Primary Immune Deficiency Research With Grant for The Mount Sinai Medical Center 3Octapharma Targets Primary Immune Deficiency Research With Grant for The Mount Sinai Medical Center 4Zyga Technology, Inc. Receives FDA 510(K) Clearance for the SImmetry™ Sacroiliac Joint Fusion System 2
(Date:3/26/2015)... Visiting Nurse Association of Northern New Jersey ... the Way, Brightening the Day, on Friday, May 1, ... Morristown, NJ. , Guests will enjoy an elegant ... delightful cuisine, an extensive silent auction and heart-warming testimony ... awards will be presented to this year’s honorees. ...
(Date:3/26/2015)... Capistrano, Calif. (PRWEB) March 26, 2015 ... and repairs, is pleased to be featured on Innovations ... Channel on March 18, 2015. The episode will ... it is live on the Pacific Medical home page ... face life threatening emergencies, it is reassuring to trust ...
(Date:3/26/2015)... Silver Spring, Md. (PRWEB) March 26, 2015 ... (PHA) fully supports the Patients’ Access to Treatments ... of Representatives this week by Reps. David B. ... bi-partisan legislation will limit cost-sharing requirements for medications ... medications more accessible by reducing patients’ out-of-pocket expenses. ...
(Date:3/26/2015)... March 26, 2015 Leading nutritional ... state-of-the-art company website: http://www.metabolicnutrition.com . The ... website creates a user-friendly experience for consumers seeking ... , The new, enhanced Metabolic Nutrition website includes: ... the company’s diverse line of products, conveniently broken ...
(Date:3/26/2015)... 26, 2015 The beauty industry united ... a man who revolutionized the business of beauty education. ... Passage; founder of Pivot Point International, Inc. Passage’s wife ... of Leo. Held at the Art Institute of Chicago, ... of industry and media leaders and served as the ...
Breaking Medicine News(10 mins):Health News:Morristown VNA Fundraiser to Honor Distinguished Community Members 2Health News:Pacific Medical Featured on the Discovery Channel 2Health News:Pacific Medical Featured on the Discovery Channel 3Health News:Pulmonary Hypertension Association Part of Coalition Supporting the Patients’ Access to Treatments Act 2Health News:Metabolic Nutrition Launches Sleek New Website with New Features and Enhanced Consumer Information 2Health News:#BeautyChangesLives Legacy Award Pays Tribute to Industry Icon Leo Passage 2Health News:#BeautyChangesLives Legacy Award Pays Tribute to Industry Icon Leo Passage 3
... mother, researchers find , , THURSDAY, Dec. 4 (HealthDay News) ... the fetus and produce immune cells that prevent the ... , This finding shows that the two coexist by ... antigens and could lead to new techniques in stem ...
... to 2007, report shows , , THURSDAY, Dec. 4 (HealthDay ... between 2000 and 2007, according to a new report, ... an international campaign to increase measles vaccination rates is ... Control and Prevention report, the number of deaths fell ...
... a,Service provider, reports they have seen a 161% increase in ... retail clients.,Attempted attacks increased from an average of 56,000 per ... to 133,000 per client per month for the last,five months. ... major,retail corporations located across the country. , ...
... economic distress and plenty, ninety percent of Americans pray, more than ... big thingsto stay healthy, to keep our jobs, and to strengthen ... and missing items. Some of us are sure God exists and ... Brandeis study published in the current issue of Poetics ...
... Dec. 4, 2008 Use of the drug ... progression of liver disease associated with the hepatitis C ... their colleagues from nine other institutions have found in ... called the HALT-C (Hepatitis C Antiviral Long-Term Treatment Against ...
... A third of Americans with diabetes do not know ... prediabetic conditions are unaware that they are at risk. ... clinical tool to identify those at highest risk for ... diabetes. If these conditions are identified early, patients may ...
Cached Medicine News:Health News:Mom's Cells Prime Fetal Immune System 2Health News:Mom's Cells Prime Fetal Immune System 3Health News:Worldwide Measles Deaths Drop Dramatically 2Health News:Worldwide Measles Deaths Drop Dramatically 3Health News:Major Retailers Experience 161% Increase in Attempted Hacker Attacks, According to SecureWorks 2Health News:Major Retailers Experience 161% Increase in Attempted Hacker Attacks, According to SecureWorks 3Health News:Major Retailers Experience 161% Increase in Attempted Hacker Attacks, According to SecureWorks 4Health News:Major Retailers Experience 161% Increase in Attempted Hacker Attacks, According to SecureWorks 5Health News:A book of common prayers 2Health News:HALT-C researchers: Interferon as long-term treatment for hepatitis C not effective 2Health News:Researcher develops screening tool to identify patients with prediabetes 2
Galt Skull Trephine with adjustable centering point and detachable cross-bar handle, 19.0 mm....
Greenberg universal retractor case, with four compartments to hold various components....
Length 6 (152 mm). Greenberg Retractor Kit is supplied with two primary bars. Primary bars attach to skull clamp....
Budde tapered retractor blade set....
Medicine Products: